Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on the Treatment of Advanced Malignant Solid Tumors With the Combination of mRNA

NCT05949775 is registered in ClinicalTrials.gov with Stemirna Therapeutics as lead sponsor.

NCT NCT05949775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05949775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on the Treatment of Advanced Malignant Solid Tumors With the Combination of mRNA
Lead sponsor
Stemirna Therapeutics
Phase
Not applicable
Overall status
Unknown status
Start date
July 20, 2023
Completion date
March 20, 2026
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignant solid tumors